AI English summary of an SEC filing — figures as filed
Kimberly-Clark KMBThe company said net sales for the 3 months ended June 30, 2024 fell 2% from the year-ago period to $5.0 billion, while organic sales rose 4%. It said changes in foreign exchange rates reduced sales by 5%, and the divestiture of its Brazil tissue and K-C Professional business reduced sales by 1%.
Key points
AI summaryThe company said net sales for the 3 months ended June 30, 2024 fell 2% from the year-ago period to $5.0 billion, while organic sales rose 4%. It said changes in foreign exchange rates reduced sales by 5%, and the divestiture of its Brazil tissue and K-C Professional business reduced sales by 1%.
The company said that operating profit for Q2 2024 was $655, compared with $113 in the year-ago period, and that adjusted operating profit was $845, up 16% from a year earlier. Results for 2024 include charges related to the 2024 Transformation Initiative.
The company said the total cost of the 2024 Transformation Initiative is expected to be approximately $1.5 billion pre-tax, with about half of that amount in cash costs. It said charges related to the initiative in Q2 were $190 pre-tax ($117 after tax), and it expects the initiative to be completed by the end of 2026.
The company said it completed the sale of the personal protective equipment business in its K-C Professional segment for $640 on July 1, 2024, subject to post-closing adjustments. It said it expects to recognize a gain from the transaction in Other (income) and expense, net in Q3 2024.
Key figures
Quarter ended June 30, 2024
- Revenue
- $5.0B
- Operating income
- $655M
- Net income
- $544M
- EPS
- $1.61
- Gross profit
- $1.8B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Net Sales and Organic Sales for Q2 2024
The company said net sales for the 3 months ended June 30, 2024 fell 2% from the year-ago period to $5.0 billion, while organic sales rose 4%. It said changes in foreign exchange rates reduced sales by 5%, and the divestiture of its Brazil tissue and K-C Professional business reduced sales by 1%.
Source · Based on the MD&A text of the filing
Operating Profit and Adjusted Operating Profit
The company said that operating profit for Q2 2024 was $655, compared with $113 in the year-ago period, and that adjusted operating profit was $845, up 16% from a year earlier. Results for 2024 include charges related to the 2024 Transformation Initiative.
Source · Based on the MD&A text of the filing
2024 Transformation Initiative Costs and Timeline
The company said the total cost of the 2024 Transformation Initiative is expected to be approximately $1.5 billion pre-tax, with about half of that amount in cash costs. It said charges related to the initiative in Q2 were $190 pre-tax ($117 after tax), and it expects the initiative to be completed by the end of 2026.
Source · Based on the MD&A text of the filing
Completion of Personal Protective Equipment Business Sale
The company said it completed the sale of the personal protective equipment business in its K-C Professional segment for $640 on July 1, 2024, subject to post-closing adjustments. It said it expects to recognize a gain from the transaction in Other (income) and expense, net in Q3 2024.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…